InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Doherty James J., Directeur Digital. Director active across 1 company, notably Acumen Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €6k. Activity tracked since 6 January 2025. The latest transaction was filed on 7 January 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
1,700 shares@ US$1.987950.0% of flowCommon StockSEC:0001628280-26-001636
1,700 shares@ US$1.98790.0018% mcap50.0% of flowCommon StockSEC:0001628280-26-001636:0
62,600 shares0Common StockSEC:0001576885-25-000017:0
3 of 3 declarations
About Doherty James J.
James J. Doherty serves as President and Chief Development Officer at Acumen Pharmaceuticals, Inc. He is responsible for the strategic and operational direction of the company, ensuring that growth objectives are met. James has a strong background in the industry, enabling him to effectively lead his teams towards operational excellence. His commitment to innovation and sustainability is central to his mission.
